{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:10:19Z","timestamp":1771654219745,"version":"3.50.1"},"reference-count":12,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Familial hypocalciuric hypercalcemia (FHH) is marked by mild to moderate hypercalcemia, normal-elevated serum PTH levels, and relative hypocalciuria. Cinacalcet, a calcimimetic therapy, has been reported to reduce symptom burden and serum calcium levels in FHH. We report 2 adult males with chronic hypercalcemia, with initial concerns for primary hyperparathyroidism. Urine calcium screening and genetic testing confirmed FHH in both patients. Shortened QTc normalized while on cinacalcet in the first patient and reductions in serum calcium and PTH levels without symptomatic hypercalcemia were noted in the second patient. Calcimimetic therapy can potentially be offered to FHH patients, particularly those with hypercalcemia symptoms, serum calcium levels &amp;gt;1\u2005mg\/dL (0.25\u2005mmol\/L) above normal or at risk of cardiac arrhythmias. Cinacalcet treatment was overall well tolerated and significantly reduced serum calcium and PTH levels in 2 adult FHH patients over time. Calcimimetic therapy has shown promise in managing persistent hypercalcemia and potential adverse events in FHH patients. Potential barriers include indefinite treatment, cost, and possible adverse effects.<\/jats:p>","DOI":"10.1210\/jcemcr\/luae096","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T17:20:54Z","timestamp":1717435254000},"source":"Crossref","is-referenced-by-count":2,"title":["Two Cases of Symptomatic Familial Hypocalciuric Hypercalcemia: Treatment Response to Calcimimetic Therapy"],"prefix":"10.1210","volume":"2","author":[{"given":"Jonathan","family":"Shakesprere","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, West Virginia University School of Medicine , Morgantown, WV 26505 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramsha","family":"Shafiq","sequence":"additional","affiliation":[{"name":"Section of Endocrinology and Metabolism, Department of Internal Medicine, West Virginia University School of Medicine , Morgantown, WV 26505 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inderpreet","family":"Madahar","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism, Corewell Health , St. Joseph, MI 49085 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh B","family":"Quinn","sequence":"additional","affiliation":[{"name":"Section of Endocrinology and Metabolism, Department of Internal Medicine, West Virginia University School of Medicine , Morgantown, WV 26505 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashan","family":"Thakkar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, West Virginia University School of Medicine , Morgantown, WV 26505 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2711-2497","authenticated-orcid":false,"given":"Adnan","family":"Haider","sequence":"additional","affiliation":[{"name":"Section of Endocrinology and Metabolism, Department of Internal Medicine, West Virginia University School of Medicine , Morgantown, WV 26505 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"issue":"5","key":"2024062702122394700_luae096-B1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"2024062702122394700_luae096-B2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4158\/EP12284.RA","article-title":"Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism","volume":"19","author":"Shinall","year":"2013","journal-title":"Endocr Pract"},{"key":"2024062702122394700_luae096-B3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4158\/EP10308.RA","article-title":"Benign familial hypocalciuric hypercalcemia","volume":"17","author":"Varghese","year":"2011","journal-title":"Endocr Pract"},{"issue":"11","key":"2024062702122394700_luae096-B4","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2017-01606","article-title":"Calcimimetic use in familial hypocalciuric hypercalcemia\u2014a perspective in endocrinology","volume":"102","author":"Marx","year":"2017","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"2024062702122394700_luae096-B5","first-page":"203","article-title":"Calcium-dependent regulation of ion channels","volume":"1","author":"Shah","year":"2006","journal-title":"Calcium Bind Proteins"},{"issue":"1","key":"2024062702122394700_luae096-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-1947-5-564","article-title":"Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series","volume":"5","author":"Rasmussen","year":"2011","journal-title":"J Med Case Rep"},{"issue":"2","key":"2024062702122394700_luae096-B7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1210\/clinem\/dgad494","article-title":"Cinacalcet reverses short QT interval in familial hypocalciuric hypercalcemia type 1","volume":"109","author":"Cuny","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2024062702122394700_luae096-B8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vph.2018.02.007","article-title":"Calcium sensing receptor expression and signalling in cardiovascular physiology and disease","volume":"107","author":"Schreckenberg","year":"2018","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"2024062702122394700_luae096-B9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-2999(91)90116-8","article-title":"Ischemia-and reperfusion-induced arrhythmias are prevented by putrescine","volume":"194","author":"Tagliavini","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2024062702122394700_luae096-B10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2796.2006.01684.x","article-title":"Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor","volume":"260","author":"Timmers","year":"2006","journal-title":"J Intern Med"},{"issue":"5","key":"2024062702122394700_luae096-B11","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1530\/EJE-15-1028","article-title":"Genetics in endocrinology: gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts","volume":"174","author":"Mayr","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"14","key":"2024062702122394700_luae096-B12","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMc1511646","article-title":"Cinacalcet for symptomatic hypercalcemia caused by AP2S1 mutations","volume":"374","author":"Howles","year":"2016","journal-title":"N Engl J Med"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/2\/6\/luae096\/58340757\/luae096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/2\/6\/luae096\/58340757\/luae096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T02:12:45Z","timestamp":1719454365000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luae096\/7686771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,5,24]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luae096","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,5,24]]},"article-number":"luae096"}}